Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

This study has been completed.

Study NCT00313781 Information provided by Pfizer

First Received: April 10, 2006 Last Updated: December 26, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2011
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)